Thursday 18, May 2017 by Georgina Enzer

King & Spalding advises Gulf Investment Corporation in healthcare acquisition

King & Spalding (in association with The Law Office of Mohammed Al-Ammar) advised Kuwait-based Gulf Investment Corporation in its acquisition of a minority stake in Sudair Pharmaceutical Company in Saudi Arabia.

Sudair Pharma is developing Sudair Specialized Pharmaceutical Complex in the Sudair Industrial City for manufacturing of high-end generic drugs for cancer treatment.

The King & Spalding team on the matter was led by partner Simon Rahimzada and associate Melissa Chan as well as counsel Mohammad Al Ammar and associates Faris Al Louzi and Bader Al-Ammar.

Features & Analyses

Investment Banking Creating a diverse bond market

In an exclusive mini roundtable, Nabilah Annuar, Banker Middle East Editor, sits down with Michael Grifferty, President of the Gulf… read more